Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Iglarlixi's trials
China Soli-CGM
iGlarLixi CGM Study in Chinese T2D Individuals After OADs
IGlarLixi (insulin glargine/lixisenatide)
Ongoing
Recruiting
Phase 4
Open NCT06671587 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
